Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study Of Subscalp Placement Of The LINQII Device
Sponsor: Mayo Clinic
Summary
The purpose of this to evaluate the capability of the FDA approved Medtronic LINQ II device (implantable cardiac monitoring device) to record EEG signals when placed temporarily in the subscalp space in patients undergoing cranial neurosurgery. No disease-directed therapeutic efficacy endpoints will be studied.
Official title: Subscalp Placement Of The LINQII Device: A First-in-human Device Feasibility Study
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2026-11
Completion Date
2027-11
Last Updated
2026-08-07
Healthy Volunteers
No
Conditions
Interventions
Medtronic LINQII
Bilateral LINQII devices will be implanted under the scalp during surgery to obtain approximately 30 minutes of brain signal recordings.
Locations (1)
Mayo Clinic in Arizona
Scottsdale, Arizona, United States